Abstract
1/2021
vol. 123
Case report
Intravitreal clindamycin in the treatment of ocular toxoplasmosis: a report of two cases
- Department of Ophthalmology, Chair of Ophthalmology and Optometry, Poznan University of Medical Sciences, Poznan, Poland
KLINIKA OCZNA 2021, 123, 1: 42–45
Online publish date: 2021/03/31
We present a report of two patients with active ocular toxoplasmosis treated with intravitreal clindamycin. The location of the retinochoroiditis close to the optic disc validated the injection of 1 mg clindamycin, even though the visual acuity was not diminished. After 7 days, inflammatory lesions and vitritis regressed significantly. Moreover, no side effects occurred.
Keywords
Toxoplasma gondii, clindamycin, intravitreal injection, toxoplasmic retinochoroiditis
Integrated with
